|Home||» Products||» Anti Cancer Drugs||» AROMASIN 25MG (EXEMESTANE)|
AROMASIN® (exemestane tablets) is a prescription medicine for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer. Treatment with AROMASIN should begin after 2 to 3 years of tamoxifen, at which time tamoxifen should be discontinued. Treatment with AROMASIN should continue for 2 to 3 years (until the completion of a total of 5 years of adjuvant treatment with tamoxifen and AROMASIN).
PRODUCT OF PFIZER COMPANY = AROMASIN 25MG
PRODUCT OF NATCO COMPANY = XTANE 25MG